Anti-PDCD1/PD-1/CD279 Antibody (Zimberelimab)
Catalog No.
F1338
Anti-PDCD1/PD-1/CD279 Antibody (Zimberelimab)
Featured Products
Zimberelimab (GLS-010) is a whole-bodyIgG4 anti-PD-1 Monoclonal antibodies, humanPD-1 ofEC50is 210 pM. Zimberelimab can effectively block thePD-L1 and PD-L2 on cell surfacePD-1 The combination ofIC50 The values are 580 pM and 670 pM, respectively. Zimberelimab has antitumor activity and is used in a variety of cancer studies, including cervical cancer, non-small cell lung cancer, and classical Hodgkin lymphoma.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.54 kDa
Dry ice
2259860-24-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
WBP3055, GLS-010, AB122
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.